These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651 [TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332 [TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation of Recurrent Hepatocellular Carcinoma After Liver Transplantation: Report of Two Cases. Akhan O; Sarıkaya Y; Köksal A; Ünal E; Çiftçi T; Akıncı D Cardiovasc Intervent Radiol; 2021 May; 44(5):807-811. PubMed ID: 33655357 [TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt occlusion via modified pringle maneuver for radiofrequency ablation of nearby tumor. Pua U; Punamiya S J Vasc Interv Radiol; 2012 Apr; 23(4):563-5. PubMed ID: 22464718 [No Abstract] [Full Text] [Related]
9. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic Shunt. Yan J; Ying X; Malhotra A; Talenfeld A; Charalel R; Lee KS; Trost D; Kesselman A Cardiovasc Intervent Radiol; 2022 May; 45(5):578-581. PubMed ID: 34859308 [TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan. Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929 [TBL] [Abstract][Full Text] [Related]
11. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up. Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651 [TBL] [Abstract][Full Text] [Related]
12. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma. Lencioni R; Crocetti L; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542 [TBL] [Abstract][Full Text] [Related]
13. Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma. Knüppel E; Bettinger D; Euringer W; Thimme R; Roessle M; Spangenberg HC; Schultheiβ M Hepatology; 2013 Dec; 58(6):2211-2. PubMed ID: 23519917 [No Abstract] [Full Text] [Related]